According to reports, the research was jointly developed by Imperial College London in the UK and the University of Munich in Germany. In the study, it was found that "Sulfonylurea" (a clinically used drug for diabetes) can be modified to change its shape after being irradiated with blue light LED. In other words, after diabetic patients take this modified drug JB253, it will not take effect immediately ( Pictured above, upper left), when he shines a blue LED on the skin (pictured above, middle, top), it will change the shape of the drug (pictured above, upper right), and start the drug to stimulate the body to release insulin. When the LED light is turned off, the drug returns to its original shape and stops working (pictured above, middle, bottom).
David Hodson, a physician at the Imperial College School of Medicine, said that this method can not only control the amount of insulin, but also reduce some complications because it allows the drug to start to work in specific parts of the body, such as the pancreas (bottom left in the picture above). This research is still in the early experimental stage, and it will take some time before it can actually be used on patients.
PREVIOUS：Xicaitong creates a vehicle-mounted LED window and a new control system
NEXT：Xicaitong releases LEDPOST special advertising software to inject a boost into the industry
RELATED NEWS
- JDI Mohara factory officially sold 2026-10-22
- Laying out optical communications, Narui Radar plans to acquire 51% of Xintai Co 2026-10-22
- Yute Optoelectronics goes public, Tongze Kangwei opens subscription 2026-10-22
- Jiangxi Dehong glass-based MiniLED second production line core equipment moved i 2026-10-22
- Liangliang Vision builds a micro-nano optical pilot platform, focusing on silico 2026-10-22
CATEGORIES
LATEST NEWS
CONTACT US
Contact: James Zhang
Phone: +86 13823393905
E-mail: jnjdz@jnjdz.com
Add: 2nd Floor, Building 4.Qiangrong East hdustrial Zone, JuweiCommunity,HangchengStreet, Eao'an District, ShenZhen
WhatsApp